Monday, May 16, 2022


Interested in Pharma? Get latest global pharma industry updates right here. Know about new development from pharma giants like J&J, Abbott, Pfizer, Sanofi, Roche, Sun Pharma, Cipla, Glenmark and other multinational pharma company. The news is aggregated from multiple leading and reliable global sources so that you can trust what you read blind folded.


Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...

Telangana caps Covid treatment charges in private hospitals

Hyderabad: The government of Telangana on Wednesday issued orders fixing treatment and investigation charges for Covid-19 in private hospitals.The state government, which had capped...

US announces to allocate 5.5 cr doses of Covid vaccines globally; India to get part of 1.6 cr earmarked for Asia

Washington: The US has announced its plan to allocate 5.5 crore doses of the Covid-19 vaccines to the rest of the world as the...

As crowds swell, AIIMS chief warns of early 3rd Covid wave

  A third wave of Covid-19 is inevitable and could hit the country earlier than expected, AIIMS director Dr Randeep Guleria warned on Saturday. Dr...

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now?

What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses,...

India should brace for third Covid-19 wave by October, say health experts

A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak...

Moderna plots 155 new hires in 2021 amid major mRNA vaccine manufacturing expansion

With a major COVID-19 vaccine manufacturing boost underway, Moderna is plotting new hires to fill its expanded production and lab space. The mRNA specialist has...

J&J exec urges industry to start thinking ‘cure’ in cancer

Amid COVID-19 lockdowns, routine cancer screenings were put on the back burner. While that may be short-term harm from the pandemic, the crisis also...

Regeneron’s COVID-19 antibodies breach a new frontier by cutting deaths in some hospitalized patients

Antibody treatments have shown little success in helping COVID-19 patients with severe disease. But a large study of hospitalized patients reveals that Regeneron’s antibody...

Bharat Biotech supplies Covaxin to 16 states

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.Company's...

US’ Centers for Disease Control calls coronavirus Delta variant a ‘variant of concern’

The US Centers for Disease Control and Prevention now called the Delta variant of the novel coronavirus, also known as B.1.617.2, a "variant of...


The pharma company in India was estimated at US$33 billion out of 2017 and generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. Indian pharma industry is right now estimated at $41 bn. The pharma industry is expected to reach $65 bn by 2024 and $120 bn by 2030.

Key point:

  • Indian pharma companies are largest vaccine producer on the planet.
  • Indian pharma companies are largest manufacturers and exporters of generic medicines.
  • Indian pharma industry generates over $11 bn of trade surplus every year.
  • Indian pharma export to United States reached USD 16.28 B in FY20.

As indicated by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharma market turnover arrived at Rs 129,015 crore (US$18.12 billion) in 2018, becoming 9.4 percent year-on-year and exports income was US$17.28 billion in FY18 and US$19.14 billion in FY19.

The Government began to support the development of medication producing by Indian Pharma companies in the mid-1960s, and with the Patents Act in 1970.

Starting at 2002, more than 20,000 pharma companies in India sold $9 billion worth of formulations and bulk drugs. 85% of these formulations were sold in India while over 60% of the bulk drugs were exported, for the most part to the United States and to Russia. 250 of the biggest pharma companies control 70% of the Indian market. Multinationals addresses just 35% of the pharmaceutical market. As far as the worldwide pharmaceutical market, India right now is considered as pharmacy of the world.

Indian pharma companies carved a niche in both the Indian and world pharmaceutical markets with their aptitude in figuring out new cycles for assembling drugs at low costs which turned into the benefit for industry. Generic drugs, with 71% piece of the pie, structure the biggest section of the Pharmaceutical industry in India. This is set to grow as exports of generics to the United States rise, as branded drugs worth $55 bn has become off-patent during 2017-2019.

Top pharma companies in India are:

Rank Name Sales (Cr. INR) * % Growth
1 Sun Pharma 12194.9 7.9
2 Abbott 10244.8 6.9
3 Cipla 8787.4 13.6
4 Mankind 6499 11.7
5 Alkem 5976.6 7.1

 Top therapies in India are:

Rank Name Sales (Cr. INR) * % Growth
1 Cardiac 20645.4 13.8
2 Anti-Infectives 17500.3 -2.5
3 Gastro Intestinal 16769.2 11.7
4 Anti-Diabetic 15838.1 8.5
5 Nutraceuticals 13547.0 18

*- MAT April 21

Growth Drivers for Pharmaceutical industry:

  • Innovation and R&D
  • Medical tourism
  • Infrastructure development
  • Strong domestic demand
  • Strong drug manufacturing

Advantage of Indian Pharma industry:

  • Cost Efficiency: Low cost of production, R&D etc.
  • Economic Drivers: High economic growth along with increasing penetration of health insurance.
  • Increased Investment: The foreign direct investment inflows in the Indian Drugs and Pharmaceutical sector stood at USD 17.75 B between April 2000 and December 2020.


  • The Pharma industry in India is the third biggest on the planet as far as volume and 14th biggest as far as worth. It contributes 3.5% of the all-out medications traded around the world.
  • India, known as the Pharmacy of the World, is the biggest supplier of generic medications and perhaps the greatest provider of minimal expense vaccines worldwide.
  • India is the second biggest PPE Kits producer with a creation limit of 10 lakh+ PPE coveralls each day.
  • Pharma industry is one of the top ten attractive sectors for foreign investment in India.
  • The pharma exports from India reach more than 200 nations around the world, including highly regulated markets of the USA, West Europe, Japan, and Australia.
  • About 20% of the global exports in generic drugs are met by India.
  • The Indian pharma industry is the third-largest in the world by volume and 14th largest in terms of value. It contributes 3.5% of the total drugs and medicines exported globally.

Source: , , sale view (IQVIA) ,

Disclaimer: This page is a web base news aggregator. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill. No legal bounding on for any post


Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.